Isogenica and Aston University Secures Funding to Develop Common Project

Isogenica, a Cambridge UK and Aston University, Birmingham UK-based specializes in the discovery and optimization of therapeutic and diagnostic peptides, proteins and antibodies, secured funding from the Technology Strategy Board.

The funding was provided for a £0.5M project to develop a gene library assembly technology invented by Dr Anna Hine and her team at Aston University.

Founded in 2000 and led by Kevin Mathews, CEO, Isogenica has an exclusive license to the above mentioned in vitro display technology that allows the generation of polypeptide and antibody libraries from which it is possible to select lead molecules with high affinity and specificity for most targets.


Join the discussion